GB0230162D0 - Compounds useful in inhibiting angiogenesis - Google Patents

Compounds useful in inhibiting angiogenesis

Info

Publication number
GB0230162D0
GB0230162D0 GBGB0230162.0A GB0230162A GB0230162D0 GB 0230162 D0 GB0230162 D0 GB 0230162D0 GB 0230162 A GB0230162 A GB 0230162A GB 0230162 D0 GB0230162 D0 GB 0230162D0
Authority
GB
United Kingdom
Prior art keywords
compounds useful
inhibiting angiogenesis
relates
degenerative disorder
vegf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0230162.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metris Therapeutics Ltd
Original Assignee
Metris Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metris Therapeutics Ltd filed Critical Metris Therapeutics Ltd
Priority to GBGB0230162.0A priority Critical patent/GB0230162D0/en
Publication of GB0230162D0 publication Critical patent/GB0230162D0/en
Priority to US10/540,645 priority patent/US20060135501A1/en
Priority to AU2003290335A priority patent/AU2003290335A1/en
Priority to JP2004563361A priority patent/JP2006513202A/ja
Priority to AU2003294143A priority patent/AU2003294143A1/en
Priority to EP03789563A priority patent/EP1581528B1/en
Priority to PCT/GB2003/005651 priority patent/WO2004058750A1/en
Priority to AT03789563T priority patent/ATE368662T1/de
Priority to CA002511506A priority patent/CA2511506A1/en
Priority to PCT/GB2003/005654 priority patent/WO2004058751A1/en
Priority to DE60315355T priority patent/DE60315355T2/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB0230162.0A 2002-12-24 2002-12-24 Compounds useful in inhibiting angiogenesis Ceased GB0230162D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0230162.0A GB0230162D0 (en) 2002-12-24 2002-12-24 Compounds useful in inhibiting angiogenesis
DE60315355T DE60315355T2 (de) 2002-12-24 2003-12-24 Piperidinyl-thiazol-carbonsäure-derivate als angiogenese-inhibitoren
AU2003294143A AU2003294143A1 (en) 2002-12-24 2003-12-24 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors
AU2003290335A AU2003290335A1 (en) 2002-12-24 2003-12-24 Piperidinyl-thiazole carboxamide derivatives for altering vascular tone
JP2004563361A JP2006513202A (ja) 2002-12-24 2003-12-24 血管形成インヒビターとしてのピペリジニル−チアゾールカルボン酸誘導体
US10/540,645 US20060135501A1 (en) 2002-12-24 2003-12-24 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors
EP03789563A EP1581528B1 (en) 2002-12-24 2003-12-24 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors
PCT/GB2003/005651 WO2004058750A1 (en) 2002-12-24 2003-12-24 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors
AT03789563T ATE368662T1 (de) 2002-12-24 2003-12-24 Piperidinyl-thiazol-carbonsäure-derivate als angiogenesis inhibitoren
CA002511506A CA2511506A1 (en) 2002-12-24 2003-12-24 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors
PCT/GB2003/005654 WO2004058751A1 (en) 2002-12-24 2003-12-24 Piperidinyl-thiazole carboxamide derivatives for altering vascular tone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0230162.0A GB0230162D0 (en) 2002-12-24 2002-12-24 Compounds useful in inhibiting angiogenesis

Publications (1)

Publication Number Publication Date
GB0230162D0 true GB0230162D0 (en) 2003-02-05

Family

ID=9950429

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0230162.0A Ceased GB0230162D0 (en) 2002-12-24 2002-12-24 Compounds useful in inhibiting angiogenesis

Country Status (9)

Country Link
US (1) US20060135501A1 (https=)
EP (1) EP1581528B1 (https=)
JP (1) JP2006513202A (https=)
AT (1) ATE368662T1 (https=)
AU (2) AU2003290335A1 (https=)
CA (1) CA2511506A1 (https=)
DE (1) DE60315355T2 (https=)
GB (1) GB0230162D0 (https=)
WO (2) WO2004058750A1 (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856685B1 (fr) * 2003-06-25 2005-09-23 Merck Sante Sas Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
WO2005116653A2 (en) * 2004-04-13 2005-12-08 Arena Pharmaceuticals, Inc. Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders
EP1637529A1 (en) 2004-09-20 2006-03-22 4Sc Ag Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof
WO2006032322A1 (en) * 2004-09-20 2006-03-30 4Sc Ag NOVEL HETEROCYCLIC NF-κB INHIBITORS
US7601745B2 (en) 2004-09-27 2009-10-13 4Sc Ag Heterocyclic NF-kB inhibitors
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
WO2007016979A2 (en) * 2005-07-29 2007-02-15 4Sc Ag NOVEL HETEROCYCLIC NF-κB INHIBITORS
GB0518494D0 (en) * 2005-09-09 2005-10-19 Argenta Discovery Ltd Thiazole compounds
EP1832586A1 (en) * 2006-03-10 2007-09-12 Oridis Biomed Forschungs- und Entwicklungs GmbH Thiazole-piperidine derivatives in treatment of diseases of liver and the pancreas
EP1832585A1 (en) * 2006-03-10 2007-09-12 ORIDIS BIOMED Forschungs- und Entwicklungs GmbH Thiazole-piperidine derivatives for treatment of hyperproliferative diseases
EP1834954A1 (en) * 2006-03-15 2007-09-19 4Sc Ag Thiazoles as NF-kB Inhibitors (proteasome inhibitors)
EP1994017A2 (en) * 2006-03-15 2008-11-26 4Sc Ag Novel heterocyclic nf-kb inhibitors
EA200801838A1 (ru) * 2006-03-15 2009-02-27 4ЭсЦэ АГ НОВЫЕ ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ NF-kB
US9090604B2 (en) 2006-07-27 2015-07-28 E I Du Pont De Nemours And Company Fungicidal azocyclic amides
WO2008013622A2 (en) * 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
JP5337711B2 (ja) * 2007-01-25 2013-11-06 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 殺菌性アミド
AU2008279447A1 (en) 2007-07-19 2009-01-29 Metabolex, Inc. N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
WO2009018844A1 (en) * 2007-08-09 2009-02-12 Oridis Biomed Forschungs- Und Entwicklungs Gmbh Thiazole-piperidine derivatives for treatment of hyperproliferative diseases
DE102007047735A1 (de) 2007-10-05 2009-04-09 Merck Patent Gmbh Thiazolderivate
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
EP2070925A1 (de) * 2007-12-10 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Neue 2-substituierte Tiazol-4-carbonsäureamid-Derivative deren Herstellung und Verwendung als Arzneimittel
EP2070924A1 (de) * 2007-12-10 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Neue 2-Hetarylthiazol-4-carbonsäureamid-Derivative, deren Herstellung und Verwendung als Arzneimittel
EP2238133A2 (en) * 2008-01-25 2010-10-13 E. I. du Pont de Nemours and Company Fungicidal amides
US8349870B2 (en) * 2008-01-25 2013-01-08 E I Du Pont De Nemours And Company Fungicidal hetercyclic compounds
BRPI0910837B1 (pt) 2008-04-30 2017-03-07 Bayer Cropscience Ag ésteres e tioésteres tiazol-4-carboxílicos, seus usos, e método e composição para controlar fungos fitopatogênicos prejudiciais
EP2334669B1 (de) * 2008-10-01 2015-12-23 Bayer Intellectual Property GmbH Heterocyclyl substituierte thiazole als pflanzenschutzmittel
US20110160222A1 (en) * 2008-11-26 2011-06-30 Metabolex, Inc. Modulators of glucose homeostasis for the treatment of diabetes and metabolic disorders
AU2009322486A1 (en) 2008-12-02 2010-06-10 E. I. Du Pont De Nemours And Company Fungicidal heterocyclic compounds
WO2010108503A1 (en) 2009-03-24 2010-09-30 Life & Brain Gmbh Promotion of neuronal integration in neural stem cell grafts
US8410127B2 (en) * 2009-10-01 2013-04-02 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
WO2011051243A1 (en) 2009-10-29 2011-05-05 Bayer Cropscience Ag Active compound combinations
KR20120101019A (ko) 2009-10-30 2012-09-12 바이엘 크롭사이언스 아게 헤테로아릴피페리딘 및 -피페라진 유도체
BR112012027762B1 (pt) * 2010-04-28 2018-06-05 Bayer Intellectual Property Gmbh Derivados de cetoheteroarilpiperidina e - piperazina como fungicidas
US8815775B2 (en) * 2010-05-18 2014-08-26 Bayer Cropscience Ag Bis(difluoromethyl)pyrazoles as fungicides
CN109674753A (zh) 2010-06-23 2019-04-26 希玛贝治疗股份有限公司 固态分散体
WO2012104273A1 (de) * 2011-02-01 2012-08-09 Bayer Cropscience Ag Heteroarylpiperidin und -piperazinderivate als fungizide
AU2017305392A1 (en) 2016-08-03 2019-02-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966748A (en) * 1975-05-08 1976-06-29 American Cyanamid Company Para-fluorophenyl-N-heterocyclic substituted butanes
GB9410534D0 (en) * 1994-05-26 1994-07-13 Lynxvale Ltd Improvements in or relating to growth factor inhibitors
EP0858457A1 (de) * 1995-10-20 1998-08-19 Dr. Karl Thomae GmbH 5-gliedrige heterocyclen, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung
US6080767A (en) * 1996-01-02 2000-06-27 Aventis Pharmaceuticals Products Inc. Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
AR012443A1 (es) * 1997-04-16 2000-10-18 Uriach & Cia Sa J Nuevas carboxamidas como inhibidores de la agregacion plaquetaria, procedimiento para su preparacion, composiciones farmaceuticas que loscontienen y uso de los mismos en la manufactura de medicamentos
MX2008002061A (es) * 2005-08-18 2008-04-16 Hoffmann La Roche Derivados de tiazolil piperidina utiles como moduladores del receptor h3.

Also Published As

Publication number Publication date
EP1581528B1 (en) 2007-08-01
EP1581528A1 (en) 2005-10-05
ATE368662T1 (de) 2007-08-15
AU2003290335A1 (en) 2004-07-22
CA2511506A1 (en) 2004-07-15
JP2006513202A (ja) 2006-04-20
AU2003294143A1 (en) 2004-07-22
WO2004058751A1 (en) 2004-07-15
US20060135501A1 (en) 2006-06-22
DE60315355T2 (de) 2008-05-08
WO2004058750A1 (en) 2004-07-15
DE60315355D1 (de) 2007-09-13

Similar Documents

Publication Publication Date Title
GB0230162D0 (en) Compounds useful in inhibiting angiogenesis
ATE328874T1 (de) Substituieten triazoldiamin derivaten und ihre verwendung als kinase inhibitoren
AU2737102A (en) Macroheterocylic compounds useful as kinase inhibitors
IL169258A0 (en) Methods of detecting the inhibition of fibrocyte formation and methods and compositions for enhancing fibrocyte formation
WO2003002595A3 (en) Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
TW200510416A (en) P38 inhibitors and methods of use thereof
IL144144A0 (en) Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
JO2320B1 (en) New pharmaceutical compound
MXPA04001037A (es) Derivados de n-fenilpirrol guanidina como ligandos del receptor de melanocortina.
TW200605886A (en) Indazoles useful in treating cardiovascular diseases
MXPA04004064A (es) Derivados heteroaromaticos de carboxamida para el tratramiento de la inflamacion.
DE60318177D1 (de) Rho-kinase inhibitoren
TW200621714A (en) Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
MA28702B1 (fr) Composes et procedes pour l'inhibition de l'interaction de proteines bcl avec des partenaires de liaison
TNSN04015A1 (en) Combination therapy for the treatment of cancer
DE60336336D1 (de) T des körpers
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
IS6914A (is) 2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum
WO2004032709A3 (en) Inhibition of src for treatment of reperfusion injury related to revascularization
AP2001002248A0 (en) Method for treating COPD.
IL161116A (en) Use of irbesartan for the preparation of medicinal products that are useful for preventing or treating pulmonary arterial hypertension
EP1372648A4 (en) KIEASE TIE2 RECEPTOR INHIBITORS FOR THE TREATMENT OF ANGIOGENIC DISEASES
ATE458724T1 (de) N-heterocyclische inhibitoren der expression von tnf-alpha
MX2007007051A (es) Nuevos derivados de tiofenpirimidiona sustituida como inhibidores de la 17??-hidroxiesteroide deshidrogenasa.
EP1581759A4 (en) METHODS OF TREATING TAXOL INDUCED SENSORY NEUROPATHY

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)